Merck holds Science and Technology Day

The picture shows Merck executives answering questions from reporters at the technology day event

Sinochem News Network News On July 8, Merck will participate in the 2021 World Artificial Intelligence Conference in Shanghai with its Life Science, Electronic Technology and Innovation Center related products and solutions, and will hold the Science and Technology Day
.

An Gaobo, President of Merck China and Managing Director of Electronic Technology Business China, pointed out that Merck sees three major trends in the development of artificial intelligence in the future, namely: the evolution of artificial intelligence will be increasingly driven by data; the progress of artificial intelligence will depend on Material innovation at the atomic level; the future of artificial intelligence and machine learning will be driven by the greater integration of displays and semiconductors in the electronics field
.

In the field of life sciences, Merck uses the latest advances in artificial intelligence software to accelerate chemical synthesis.
Through the development of SYNTHIA organic reverse synthesis analysis software, it helps experts to access and use the large amount of data collected in decades of research on chemical synthesis, so as to make faster Patients provide effective drugs
.

Li Yi, Director of Innovation Projects and Incubation of Merck China Innovation Center, said that the China Innovation Centers set up by Merck in Shanghai and Guangdong are committed to cooperating with start-ups, academic institutions, industry partners and local governments to continuously search for, incubate and invest in medical health, Innovation opportunities in life sciences, electronic technology, and cross-business fields bring new technologies and solutions to the market
.
In recent years, Merck China Innovation Center has used Merck China Accelerator, Merck China Seed Fund and other platforms to search for, incubate and invest in outstanding artificial intelligence start-ups and projects, including artificial intelligence chips, artificial intelligence assisted reproduction, and optimized clinical trials, etc.